Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Electronic (PDF)
Enterprisewide
Forecast Insight: Parkinson's Disease - Market Upgrade following Evidence of Disease Slowing with Azilect
Datamonitor, Sep 2008, Pages: 123
Description
Table of Contents
Companies Mentioned
Enquire before Buying
Send to a Friend
- Teva/Lundbeck
- GlaxoSmithKline
- UCB
Customers who bought this item also bought
Stakeholder Insight: Parkinsons Disease - Evidence of neuroprotection essential to progress treatment dynamics
Pipeline and Commercial Insight: Parkinsons Disease - Market to grow as first round of lifecycle management strategies succeed
Alzheimers and Parkinsons Disease - Global Strategic Business Report
Pipeline Insight: Parkinsons Disease And Restless Legs Syndrome - Reformulations Set To Drive Near-Term Growth
Stakeholder Opinions: Parkinsons Disease - Review of Key Commercial Opportunities in the Symptomatic Treatment Market
Commercial Insight: Parkinsons Disease - Increased Focus on Earlier Treatment and Managing Levodopa Complications Will Drive Market Growth
Commercial Insight: Parkinson's Disease - Japan and Europe to Drive Total Market Growth
Pipeline and Commercial Insight: Alzheimers Disease - Scenario Forecasts Reveal Vast Market Potential
Commercial Insight: Inflammatory Bowel Disease - Convenience and Compliance Drive Market Success
Parkinson's Disease Market Forecast
Forecast Insight: Inflammatory Bowel Disease - New product launches sustain long-term market growth
Mild Cognitive Impairment - Unlocking the Potential of Prodromal Alzheimer's Disease and Beyond
Top of page
All rights reserved. © Copyright 2009 Research and Markets
0
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
